| Officer | Age | Source |
|---|---|---|
|
Andrea Pfeifer
Also a director
Chief Executive Officer and Director
|
68 | |
|
Martin Zuegel
Also a director
Interim CEO
Title from the Form 4 dated Jun 11, 2026
|
63 | |
|
Christopher Roberts
Chief Financial Officer
|
37 | |
|
Piergiorgio Donati
Chief Operating Officer
Title from the Form 3 dated Mar 20, 2026
|
55 | |
|
Matthias Maurer
SVP General Counsel
|
44 | |
|
Olivier Sol
VP, Clinical Safety Officer
|
59 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Related-party transactions come from the company’s proxy statement. AC Immune SA has not filed one with the SEC.
Loading...